accountNEW YORK - Pfizer Inc., the world's largest drugmaker, said Tuesday it completed its acquisition of King Pharmaceuticals Inc. for $3.6 billion.In January, Pfizer completed the tender offer for Bristol, Tenn.-based King and said it would close the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer completes buyout of King Pharmaceuticals
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account